• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Biodesix Inc (NQ: BDSX )

    1.370 +0.040 (+3.01%)
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Biodesix Inc

    < Previous 1 2 3 4 5 6 7 Next >
    Biodesix, Inc. (BDSX) Q2 2021 Earnings Call Transcript
    BDSX earnings call for the period ending June 30, 2021. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    Biodesix Announces Second Quarter 2021 Results and Highlights
    From Biodesix, Inc.
    Via Business Wire
    Earnings Scheduled For August 10, 2021
    Companies Reporting Before The Bell • Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter. • Fulcrum Therapeutics (NASDAQ:... 
    Via Benzinga
    Biodesix to Present at the Canaccord Genuity 41st Annual Growth Conference
    From Biodesix, Inc.
    Via Business Wire
    The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc... 
    Via Benzinga
    Exposures COVID-19
    Earnings Scheduled For May 11, 2021
    Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its fourth quarter. • ReWalk Robotics (NASDAQ:RWLK) is... 
    Via Benzinga
    The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 28) AbbVie Inc. (NYSE: ABBV)... 
    Via Benzinga
    Exposures Product Safety
    Biodesix to Report Second Quarter 2021 Financial Results on August 10, 2021
    From Biodesix, Inc.
    Via Business Wire
    The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 22) Bio-Techne Corporation (... 
    Via Benzinga
    The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 20) Alnylam Pharmaceuticals,... 
    Via Benzinga
    Looking Into Biodesix's Return On Capital Employed
    During Q1, Biodesix's (NASDAQ:BDSX) reported sales totaled $28.87 million. Despite a 110.44% in earnings, the company posted a loss of $5.58 million. In Q4, Biodesix brought in $... 
    Via Benzinga
    Biodesix Announces Presentation on Novel Proteomic Techniques in Partnership with Seer
    From Biodesix, Inc.
    Via Business Wire
    The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) Ambrx Biopharma Inc. (NYSE:... 
    Via Benzinga
    Topics Product Recall
    Exposures COVID-19 Legal Product Safety
    Stocks That Hit 52-Week Lows On Wednesday
    Before 10 a.m. ET on Wednesday, 49 companies set new 52-week lows. Noteworthy Highlights: The largest company in terms of market cap to set a new 52-week low was China... 
    Via Benzinga
    Biodesix Announces Commercial Availability of SARS CoV-2 Neutralization Antibody Test
    From Biodesix, Inc.
    Via Business Wire
    Stocks That Hit 52-Week Lows On Tuesday
    Tuesday morning, 51 companies reached new 52-week lows. Noteworthy Highlights: China Life Insurance Co (NYSE:LFC) was the largest company by market cap to set a new... 
    Via Benzinga
    Biodesix Partners with Datavant to Enhance Value of Lung Cancer Databank
    From Biodesix
    Via Business Wire
    The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14) Alkermes plc (NASDAQ: ALKS... 
    Via Benzinga
    Biodesix: Return On Capital Employed Insights
    During Q1, Biodesix's (NASDAQ:BDSX) reported sales totaled $28.87 million. Despite a 110.44% in earnings, the company posted a loss of $5.58 million. Biodesix collected $27.03... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Gainers Pieris Pharmaceuticals (NASDAQ:PIRS) stock moved upwards by 20.74% to $4.54 during Wednesday's pre-market session. The market value of their outstanding shares... 
    Via Benzinga
    Biodesix to Present at the William Blair 41st Annual Growth Stock Conference
    From Biodesix, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Friday's After-Market Session
    Gainers Sio Gene Therapies (NASDAQ:SIOX) ... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Monday
    On Monday morning, 15 companies hit new 52-week lows. Noteworthy Highlights: Canadian Pacific Railway (NYSE:CP) was the largest firm by market cap to set a new 52-... 
    Via Benzinga
    Biodesix, Inc. (BDSX) Q1 2021 Earnings Call Transcript
    BDSX earnings call for the period ending March 31, 2021. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    Biodesix Announces First Quarter 2021 Results
    From Biodesix, Inc.
    Via Business Wire
    Biodesix Announces Intent to Launch Liquid Biopsy Next Generation Sequencing Test with Unprecedented Turnaround Time
    From Biodesix, Inc.
    Via Business Wire
    Biodesix Announces Presentation on SARS-CoV-2 Neutralizing Antibody Testing for Individual Vaccine Response and Commercial Launch Plans
    From Biodesix, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Monday's Intraday Session
    Gainers Reviva Pharmaceuticals (NASDAQ:RVPH) shares rose 72.91% to $7.47 during Monday's regular session. Reviva Pharmaceuticals's stock is trading at a volume of... 
    Via Benzinga
    Biodesix to Report First Quarter 2021 Financial Results on May 11, 2021
    From Biodesix, Inc.
    Via Business Wire
    Biodesix Announces Presentation on Use of Biomarker-Based Risk Assessment to Inform Lung Nodule Management
    From Biodesix, Inc.
    Via Business Wire
    < Previous 1 2 3 4 5 6 7 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.